196 related articles for article (PubMed ID: 27371991)
21. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract][Full Text] [Related]
22. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
[TBL] [Abstract][Full Text] [Related]
23. Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?
Horne ZD; Karukonda P; Kalash R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Bochmeier MM; Berger JL; Taylor SE; Sukumvanich P; Beriwal S
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):157-164. PubMed ID: 30605752
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
[TBL] [Abstract][Full Text] [Related]
25. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional image-guided combined intracavitary and interstitial high-dose-rate brachytherapy in cervical cancer: A systematic review.
Li F; Lu S; Zhao H; Mu X; Mao Z
Brachytherapy; 2021; 20(1):85-94. PubMed ID: 33039332
[TBL] [Abstract][Full Text] [Related]
27. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
Paton AM; Chalmers KE; Coomber H; Cameron AL
Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
[TBL] [Abstract][Full Text] [Related]
28. Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.
Boyrie S; Charra-Brunaud C; Harter V; Ducassou A; Kirova Y; Barillot I; Krzisch C; Lang P; Baron MH; Montbarbon X; Delannes M; Peiffert D
Brachytherapy; 2014; 13(4):326-31. PubMed ID: 24946972
[TBL] [Abstract][Full Text] [Related]
29. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
30. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
32. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
33. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
34. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
[TBL] [Abstract][Full Text] [Related]
35. Four-Dimensional Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Systematic Review and Meta-Regression Analysis.
Li F; Shi D; Bu M; Lu S; Zhao H
Front Oncol; 2022; 12():870570. PubMed ID: 35860574
[TBL] [Abstract][Full Text] [Related]
36. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
[TBL] [Abstract][Full Text] [Related]
37. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
38. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
39. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
40. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]